Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bipolar Disorder
100%
Schizophrenia Symptoms
100%
Gene Network
100%
Beta-catenin
100%
Chip-based
100%
Glycogen Synthase kinase-3β (GSK-3β)
80%
Fetal Brain
40%
Brain Tissue
40%
Autism Spectrum Disorder
40%
Genome-wide Association Study
40%
Lithium
40%
Transcription Factor
20%
Signal Transduction Pathway
20%
Chromatin Immunoprecipitation (ChIP)
20%
Transcriptional Activation
20%
Fibroblast Growth Factor Receptor 1 (FGFR1)
20%
Phosphoinositide Signaling
20%
Microarray
20%
Schizophrenia
20%
Schizophrenia Spectrum Disorders
20%
Therapeutic Implications
20%
Copy number Variation
20%
Expression Study
20%
Response Pathways
20%
Transcription Inhibition
20%
Phosphoinositides
20%
Expression Profiling
20%
Microarray Expression
20%
Annealing
20%
Therapeutic Concentrations
20%
Genome-wide Search
20%
Molecular Network
20%
SNAP29
20%
β-catenin Signaling
20%
Biological Structures
20%
PCDH9
20%
CACNA1B
20%
Enrichment Material
20%
Therapeutic Action
20%
Lithium Salt
20%
Abnormal Activation
20%
Neuroscience
Promoter Region
100%
Bipolar Disorder
100%
Catenin
100%
Schizophrenia
100%
Glycogen Synthase Kinase 3beta
80%
Phosphatidylinositide
40%
Genome-Wide Association Study
40%
Autism Spectrum Disorder
40%
Transcription Factors
20%
Mental Disorder
20%
Signal Transduction Pathway
20%
Immunoprecipitation
20%
Transactivation
20%
Transcription Initiation
20%
Chromatin
20%
Lithium Salt
20%
Beta-Catenin
20%
Fibroblast Growth Factor Receptor 1
20%
Biochemistry, Genetics and Molecular Biology
Promoter Region
100%
Glycogen Synthase Kinase 3
100%
Catenin
100%
Gene Network
100%
Candidate Gene
50%
Genome-Wide Association Study
50%
Phosphoinositide
50%
Signal Transduction
25%
Transcription Factors
25%
Chromatin Immunoprecipitation
25%
Transactivation
25%
Transcription Initiation
25%
Fibroblast Growth Factor Receptor 1
25%
Molecular Network
25%
Beta-Catenin
25%